Management Team

Inês Pimenta de Castro, PharmD, Ph.D., joned 272BIO as our Head of Portfolio Management in March 2022. Ines’ responsibilities include strategic scientific leadership, management of antibody discovery projects, external collaborations, partnerships management and operational activities.

Before joining 272BIO, Inês worked as a Senior Scientist, at one of the leading CROs specialized in the discovery of therapeutic monoclonal antibodies. There she was leading the biggest team of the company, focusing on developing new therapeutic drugs, under different antibody formats,  in oncology, neurology, and immunology.

She holds a Ph.D. in Molecular Medicine, developed at the MRC Toxicology Unit in Leicester, and was awarded a Postdoctoral Fellowship at the Gulbenkian Institute in Lisbon.